Smileyscope pioneered and patented a powerful new approach to digital therapeutics – virtual reality neuromodulation.
Smileyscope's innovative therapeutic platform underwent rigorous clinical studies, and has changed pediatric needle practice worldwide. International vascular access guidelines now recommend Smileyscope.
Virtual reality neuromodulation is improving patient and healthcare outcomes. Read on to see how we enhance needle experiences.
Smileyscope redefines fear through positive technology
Evidence based virtual reality designed for healthcare use
Over 20 effective
Virtual Reality experiences
Streamlined hardware with Advanced Anti-microbial Impregnation
Comprehensive relaxation library
with music therapy
Smileyscope is an Australian Therapeutic Goods Administration Class I medical device, meets stringent standards for CE marking, and complies with health and safety standards ISO 14971:2012; 62366: 2008; and biological standard ISO 10993-1:2018. Smileyscope adheres to the United States’ Food and Drug Administration’s Policy for Mobile Medical Applications and Enforcement Policy for Digital Health Devices 21 CFR 882.5801
"My child has had
over 300 procedures.
This was the first time
he has not cried"
Parent of a 5 year old
Statutory Disclaimer: Patient in clinical trial who did not receive compensation and is not an immediate family member, of an individual who is involved with the production, sale, supply or marketing of the goods.